POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19
20 sept. 2022 21h31 HE | POP Biotechnologies, Inc.
BUFFALO, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the commencement of two Phase 3 clinical studies of...
With 8.8 % CAGR, Influenza Vaccine Market Size worth USD 13.58 billion by 2029
13 sept. 2022 06h14 HE | Fortune Business Insights
Pune, India, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The global influenza vaccine market size was USD 7.02 billion in 2021 and USD 7.54 billion in 2022. It is anticipated to reach USD 13.58 billion by...
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative Medicines
07 sept. 2022 02h00 HE | BioNTech SE
JERUSALEM, Israel, and MAINZ, Germany, September 7, 2022 —BioNTech SE (Nasdaq: BNTX) announced today that Prof. Ugur Sahin, CEO and Co-founder of BioNTech, visited Israel to meet with the Minister of...
BioNTech CEO Ugur Sahin besuchte Israel: Diskussion möglicher Zusammenarbeit bei der Pandemievorsorge und der Entwicklung innovativer Medikamente
07 sept. 2022 02h00 HE | BioNTech SE
JERUSALEM, Israel, und MAINZ, Deutschland, 7. September 2022 — BioNTech SE (Nasdaq: BNTX, „BioNTech“) gab heute bekannt, dass Prof. Ugur Sahin, CEO und Mitbegründer von BioNTech, nach Israel gereist...
HilleVax to Participate in J.P. Morgan Biotech – 2022 Conference Call Series
01 sept. 2022 17h18 HE | HilleVax, Inc.
BOSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Needle-Free Injection System Market Worth USD 411.31 Million by 2028 at 17.7% CAGR Global Analysis by Product (Fillable Needle Free Injectors, Prefilled Needle Free Injectors)
01 sept. 2022 06h31 HE | The Insight Partners
New York, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Needle-Free Injection System Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
HilleVax Announces Positive Recommendation from Safety Data Monitoring Committee for NEST-IN1 Phase 2b Clinical Trial of HIL-214 Norovirus Vaccine Candidate
31 août 2022 07h00 HE | HilleVax, Inc.
Enrollment of remaining subjects in NEST-IN1 has resumed Immunogenicity results from the first 200 subjects expected in Q4 2022 BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc....
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
23 août 2022 06h45 HE | BioNTech SE
Updated analysis from 34 cases occurring at least seven days following a three-dose regimen showed 73.2% vaccine efficacy among children ages 6 months through 4 yearsThe vaccine efficacy remained...
Pfizer und BioNTech geben Update zur Wirksamkeit ihres COVID-19-Impfstoffs bei Kindern von 6 Monaten bis 4 Jahren
23 août 2022 06h45 HE | BioNTech SE
Daten einer weiterführenden Analyse mit 34 Fällen, die mindestens sieben Tage nach Verabreichung der primären Impfserie bestehend aus drei Dosen auftraten, zeigen eine Impfstoffwirksamkeit von 73,2 %...
New to The Street TV / Newsmax TV Announces Its Seven Corporate Interviews for This Week’s TV Broadcast, Episode #377, August 21, 2022, 10-11 AM ET
19 août 2022 09h35 HE | FMW Media Works Corp
NEW YORK, Aug. 19, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New To The Street / Newsmax TV announces its 377th show line-up, which features the following seven (7) Corporate interviews, airing Sunday,...